Oaktree Capital Management
VC Fund
Los Angeles, United States
Oaktree Capital Management is a leader among global investment managers specializing in alternative investments. Our competitive advantages include our experienced team of investment professionals, a global platform and a unifying investment philosophy that is complemented by a set of core business principles. Our expertise in investing across thecapital structure has allowed us to cultivate a diversified mix of global investment strategies in three categories: credit, equity, and real estate. We emphasize an opportunistic, value-oriented and risk-controlled approach to investing in these asset classes. Oaktree's mission is to deliver superior investment results with risk under control and to conduct our business with the highest integrity.
- Total investments:
- 120
- Last investment:
- Lead investor:
- 69%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Oaktree Capital Management invests in
Stages Oaktree Capital Management invests in
Countries Oaktree Capital Management invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
|
|
|||
|
|
|||
|
|
Investment Focus
Industry
- Financial Services 14 (12%)
- Biotechnology 12 (10%)
- Health Care 11 (9%)
- Manufacturing 9 (8%)
- Information Technology 9 (8%)
Stage
- Private Equity 23 (19%)
- Debt Financing 19 (16%)
- Post-IPO Debt 17 (14%)
- Post-IPO Equity 12 (10%)
- Funding Round 9 (8%)
Country
- United States 60 (50%)
- United Kingdom 11 (9%)
- Canada 6 (5%)
- Australia 5 (4%)
- India 3 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Bruce Karsh
Co-Chairman and Chief Investment Officer
|
Co-Chairman and Chief Investment Officer | Total investments: 2 | Find email | |
|
Eric Johnson
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
|
Greg Share
Managing Director
|
Managing Director | Total investments: 1 | Find email | |
|
HOWARD MARKS
Co-Chairman
|
Co-Chairman | Total investments: 0 | Find email | |
|
Ian Schapiro
Managing Director & Portfolio Manager
|
Managing Director & Portfolio Manager | Total investments: 0 | Find email | |
| See all 18 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
QVC Group manages brands like QVC and HSN, offering products via TV, online, and mobile shopping platforms. | $600M / Debt Financing / Aug 06, 2026 | |
|
|
IDF & Oaktree - JV is a specialized project finance vehicle created to deploy behind-the-meter Bloom Energy fuel cells for Nebius' AI cloud infrastructure. The entity operates as an independent, on-site utility provider, bypassing traditional grid-connection delays to supply dedicated, clean power for high-density computing workloads. | Private Equity / Jul 16, 2026 | |
|
|
Northbase Finance acts as a strategic partner to Compass Energy Systems. | $300M / Debt Financing / Jul 15, 2026 | |
|
|
Temple View Capital provides bridge loans, fix & flip rehab loans and rental loans for real estate investors. | Private Equity / Jul 15, 2026 | |
|
|
Ionic Digital is an innovator in the bitcoin mining industry. | $400M / Venture - Series Unknown / Jun 26, 2026 | |
|
|
Quantum Corp. is the global specialist in backup, recovery, and archive. From small businesses to multinational enterprises, more than 50,000 customers trust Quantum to solve their data protection, retention and management challenges. Quantum's best-of-breed, open systems solutions provide significant storage efficiencies and cost savingswhile minimizing risk and protecting prior investments. They include three market-leading, highly scalable platforms: DXi®-Series disk-based deduplication and replication systems for fast backup and restore, Scalar® tape automation products for disaster recovery and long-term data retention, and StorNext® data management software for high-performance file sharing and archiving | $100M / Post-IPO Equity / Jun 01, 2026 | |
|
|
Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. Aquestive is committed to addressing immediate CNS challenges by furthering its strong pipeline of products. As the undisputed leader in developing and deliveringdrugs via its proprietary technologies, the Company also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms. | $55M / Post-IPO Debt / May 12, 2026 | |
|
Spectrum Brand-Home & Personal Care business
|
Spectrum Brand-Home & Personal Care business is focused on driving innovation and providing exceptional customer service. | $60M / Debt Financing / May 04, 2026 | |
|
Spectrum Brand-Home & Personal Care business
|
Spectrum Brand-Home & Personal Care business is focused on driving innovation and providing exceptional customer service. | $67M / Private Equity / May 04, 2026 | |
|
|
Establishment Labs is a medical technology company with a strong emphasis on innovation that designs, develops, manufactures and markets an innovative product portfolio. Its CE-marked Motiva Implants® line of silicone breast implants (http://www.motivaimplants.com) utilizes ultra-high purity medical-grade silicone and is subject to thestrictest quality assurance testing throughout the manufacturing process. Motiva Implants are sold in more than 60 countries worldwide. Puregraft®’s FDA cleared and CE-Marked technology provides plastic surgeons with purified fat for reinjection on the sterile field and is used in hospitals and clinics around the world. Divina® is a proprietary 3D imaging technology for full integration in consultation and surgical planning of unique solutions for breast aesthetics and reconstruction. All manufacturing facilities are fully compliant with both FDA and ISO applicable standards. | $300M / Post-IPO Debt / Apr 30, 2026 | |
| See all 120 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Oaktree Capital Management invest in?
Oaktree Capital Management invests primarily in Financial Services, Biotechnology and Health Care startups, most often at Private Equity and Debt Financing stage. Most of the 120 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Oaktree Capital Management?
Public channels for Oaktree Capital Management include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Oaktree Capital Management?
The team at Oaktree Capital Management includes Bruce Karsh (Co-Chairman and Chief Investment Officer), Eric Johnson (Managing Director) and Greg Share (Managing Director), among 18 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!